Serum sTWEAK levels in chronic periodontitis and type 2 diabetes mellitus.

作者: Anirudh B. Acharya , Apoorva Chandrashekar , Swetha Acharya , Leena Shettar , Srinath Thakur

DOI: 10.1016/J.DSX.2019.03.027

关键词:

摘要: Abstract Aim The two-way relationship between diabetes mellitus and periodontitis has been extensively studied with various interconnected biomarkers sharing a link. Soluble Tumour Necrosis Factor-like Weak inducer of apoptosis (sTWEAK) is gaining attention as an important mediator in chronic inflammatory diseases. Thus, the aim this study was to detect, estimate compare levels sTWEAK serum health, (CP), CP type 2 (T2DM). Materials methods Forty-five participants 18 65 years were divided into groups 15 each Group 1: healthy, 2: CP, 3: CP + T2DM. Clinical periodontal parameters glycemic status assessed. estimated using commercially available ELISA kit. data statistically analyzed. Results detected all participants. Significant differences observed for sTWEAK; highest lower lowest In diseased groups, clinical correlated positively other, whereas negatively parameters. Conclusion literature reports concentrations systemic T2DM which may be comparable our observations CP + T2DM when compared health its negative correlation suggesting association both levels. However, not necessarily elevated previously reported, hence potential clarification T2DM.

参考文章(49)
Stuart J. Perper, Beth Browning, Linda C. Burkly, Shawn Weng, Cindy Gao, Keith Giza, Lihe Su, Leticia Tarilonte, Thomas Crowell, Luis Rajman, Laura Runkel, Martin Scott, Gerald J. Atkins, David M. Findlay, Timothy S. Zheng, Henry Hess, TWEAK Is a Novel Arthritogenic Mediator The Journal of Immunology. ,vol. 177, pp. 2610- 2620 ,(2006) , 10.4049/JIMMUNOL.177.4.2610
N. G. Kataria, P. M. Bartold, A. A. S. K. Dharmapatni, G. J. Atkins, C. A. Holding, D. R. Haynes, Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis. Journal of Periodontal Research. ,vol. 45, pp. 564- 573 ,(2010) , 10.1111/J.1600-0765.2010.01275.X
Mariana J. Kaplan, Donna Ray, Ru-Ran Mo, Raymond L. Yung, Bruce C. Richardson, TRAIL (Apo2 Ligand) and TWEAK (Apo3 Ligand) Mediate CD4+T Cell Killing of Antigen-Presenting Macrophages The Journal of Immunology. ,vol. 164, pp. 2897- 2904 ,(2000) , 10.4049/JIMMUNOL.164.6.2897
Sean Campbell, Linda C. Burkly, Hua-Xin Gao, Joan W. Berman, Lihe Su, Beth Browning, Timothy Zheng, Lena Schiffer, Jennifer S. Michaelson, Chaim Putterman, Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells The Journal of Immunology. ,vol. 176, pp. 1889- 1898 ,(2006) , 10.4049/JIMMUNOL.176.3.1889
Maria Retzepi, Mark P. Lewis, Nikolaos Donos, Effect of diabetes and metabolic control on de novo bone formation following guided bone regeneration. Clinical Oral Implants Research. ,vol. 21, pp. 71- 79 ,(2010) , 10.1111/J.1600-0501.2009.01805.X
Dana Graves, Cytokines That Promote Periodontal Tissue Destruction Journal of Periodontology. ,vol. 79, pp. 1585- 1591 ,(2008) , 10.1902/JOP.2008.080183
P. Meisel, A. Siegemund, R. Grimm, F.H. Herrmann, U. John, C. Schwahn, T. Kocher, The Interleukin-1 Polymorphism, Smoking, and the Risk of Periodontal Disease in the Population-based SHIP Study Journal of Dental Research. ,vol. 82, pp. 189- 193 ,(2003) , 10.1177/154405910308200308
Jeffrey A. Winkles, The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nature Reviews Drug Discovery. ,vol. 7, pp. 411- 425 ,(2008) , 10.1038/NRD2488
Miguel Ramalho-Santos, Soonsang Yoon, Yumi Matsuzaki, Richard C Mulligan, Douglas A Melton, "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells Science. ,vol. 298, pp. 597- 600 ,(2002) , 10.1126/SCIENCE.1072530
Ana Belen Sanz, Maria D Sanchez-Niño, Alberto Ortiz, None, TWEAK, a multifunctional cytokine in kidney injury Kidney International. ,vol. 80, pp. 708- 718 ,(2011) , 10.1038/KI.2011.180